23190-84-3,MFCD00102307
Catalog No.:AA006YAW

23190-84-3 | 2-Amino-3-cyanoquinoxalinediium-1,4-diolate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
500mg
>95%
2 weeks  
$531.00   $372.00
- +
1g
>95%
2 weeks  
$552.00   $386.00
- +
5g
>95%
2 weeks  
$817.00   $572.00
- +
10g
>95%
2 weeks  
$1,000.00   $700.00
- +
25g
>95%
2 weeks  
$1,705.00   $1,193.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA006YAW
Chemical Name:
2-Amino-3-cyanoquinoxalinediium-1,4-diolate
CAS Number:
23190-84-3
Molecular Formula:
C9H6N4O2
Molecular Weight:
202.1695
MDL Number:
MFCD00102307
SMILES:
N#Cc1[n+]([O-])c2ccccc2[n+](c1N)[O-]
Properties
Computed Properties
 
Complexity:
289  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.5  

Literature

Title: Design of novel iron compounds as potential therapeutic agents against tuberculosis.

Journal: Journal of inorganic biochemistry 20101101

Title: New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agents.

Journal: European journal of medicinal chemistry 20100701

Title: Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.

Journal: Bioorganic & medicinal chemistry 20090215

Title: New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.

Journal: Journal of inorganic biochemistry 20080101

Title: Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.

Journal: Bioorganic & medicinal chemistry 20060815

Title: Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.

Journal: Journal of inorganic biochemistry 20060801

Title: Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.

Journal: Journal of inorganic biochemistry 20060201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 23190-84-3
Tags:23190-84-3 Molecular Formula|23190-84-3 MDL|23190-84-3 SMILES|23190-84-3 2-Amino-3-cyanoquinoxalinediium-1,4-diolate
Catalog No.: AA006YAW
23190-84-3,MFCD00102307
23190-84-3 | 2-Amino-3-cyanoquinoxalinediium-1,4-diolate
Pack Size: 500mg
Purity: >95%
2 weeks
$531.00 $372.00
Pack Size: 1g
Purity: >95%
2 weeks
$552.00 $386.00
Pack Size: 5g
Purity: >95%
2 weeks
$817.00 $572.00
Pack Size: 10g
Purity: >95%
2 weeks
$1,000.00 $700.00
Pack Size: 25g
Purity: >95%
2 weeks
$1,705.00 $1,193.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA006YAW
Chemical Name: 2-Amino-3-cyanoquinoxalinediium-1,4-diolate
CAS Number: 23190-84-3
Molecular Formula: C9H6N4O2
Molecular Weight: 202.1695
MDL Number: MFCD00102307
SMILES: N#Cc1[n+]([O-])c2ccccc2[n+](c1N)[O-]
Properties
Complexity: 289  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 15  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.5  
Literature fold

Title: Design of novel iron compounds as potential therapeutic agents against tuberculosis.

Journal: Journal of inorganic biochemistry20101101

Title: New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agents.

Journal: European journal of medicinal chemistry20100701

Title: Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.

Journal: Bioorganic & medicinal chemistry20090215

Title: New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.

Journal: Journal of inorganic biochemistry20080101

Title: Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.

Journal: Bioorganic & medicinal chemistry20060815

Title: Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.

Journal: Journal of inorganic biochemistry20060801

Title: Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.

Journal: Journal of inorganic biochemistry20060201

Building Blocks More >
2117-71-7
2117-71-7
1,1,2,2,3,3,4,4-Octaphenyltetragermetane
AA006YP5
478040-59-4
478040-59-4
6-Iodoimidazo[1,2-a]pyridine-2-carboxylic acid
AA006Z52 | MFCD02186210
43134-76-5
43134-76-5
4-Acetamido-2-aminobenzoic acid
AA006ZJB | MFCD03768922
22123-09-7
22123-09-7
6-Methyl-4-(trifluoromethyl)pyrid-2-yl hydrazine
AA007023 | MFCD00052901
220641-87-2
220641-87-2
N-methyloxan-4-amine
AA0070IB | MFCD06658492
220137-70-2
220137-70-2
1-(Piperidin-1-ylmethyl)cyclohexanamine
AA0070XV | MFCD07801143
42816-53-5
42816-53-5
5-Aminoindoline-2,3-dione
AA0071D3 | MFCD00091972
4437-65-4
4437-65-4
4-METHYLQUINOLIN-2-THIONE
AA0071VD | MFCD00461554
214360-49-3
214360-49-3
3-Acetylphenylboronic acid, pinacol ester
AA0072AG | MFCD05863923
1263-89-4
1263-89-4
Paromomycin sulfate salt
AA0072PN | MFCD00079278
Submit
© 2017 AA BLOCKS, INC. All rights reserved.